Jubilant Gets FDA Nod for Generic Diuretic Medicine

by Kathy Jones on  April 28, 2014 at 6:15 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Jubilant Life Sciences announced on Friday that it has received approval from the US Food and Drugs Administration (FDA) to market a generic diuretic medicine.
 Jubilant Gets FDA Nod for Generic Diuretic Medicine
Jubilant Gets FDA Nod for Generic Diuretic Medicine

The company has received abbreviated new drug application approval to market Spironolactone tablets (25 mg, 50 mg and 100 mg). These tablets are the generic version of GD Searle's Aldactone. Spironolactone is used to treat fluid retention caused by conditions such as congestive heart failure and cirrhosis of the liver.

Jubilant said in a press release that it will launch the drug in the first quarter of the fiscal year 2015-16. The market size of this diuretic is estimated to be $87 million per year.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Benefits of Blood Pressure Tablets on your Health Congestive Heart Failure Combination Therapy for High Blood Pressure 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive